Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE: 300519)
Health Care · Pharmaceuticals · CN
CN¥14.29
-3.45% today · -16.4% 1Y
Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE: 300519) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $340.12M and employs 309 people.
Over the last twelve months the share price has lost 16.4%, trading between 11.53 and 18.25.
Tweenvest scores Zhejiang Xinguang Pharmaceutical Co., Ltd. across four factors: quality 83/100, value 45/100, growth 9/100, dividend 65/100. Its strongest factor is quality.
300519 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $340.12M
- Revenue (TTM)
- $37.78M
- P/E
- 40.74
- EPS
- 0.35
- Dividend yield
- 2.10%
- Beta (5Y)
- 0.30
- 52-week high
- CN¥18.25
- 52-week low
- CN¥11.53
- Avg volume (3M)
- —
- Shares outstanding
- 160.00M
- Employees
- 309
- Next earnings
- —
About Zhejiang Xinguang Pharmaceutical Co., Ltd.
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China.
- ISIN
- CNE1000027T3
- Founded
- 1998
- Listed since
- Jun 24, 2016
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,247.37 | -0.64% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.00 | +1.02% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.91 | -1.08% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.03 | -0.14% |
Figures last refreshed Aug 18, 2026.